Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
百度集團-SW
09888
5
京東健康
06618
| (FY)2025/03/31 | (FY)2024/03/31 | (Q4)2024/03/31 | (Q3)2023/12/31 | (Q2)2023/09/30 | (Q1)2023/06/30 | (FY)2023/03/31 | (Q4)2023/03/31 | (Q3)2022/12/31 | (Q2)2022/09/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 營業總收入 | -2.86%22.54億 | 16.47%23.2億 | 0.77%5.49億 | 51.28%6.66億 | 14.37%5.41億 | 5.65%5.64億 | -5.79%19.92億 | 6.33%5.45億 | -4.05%4.4億 | -16.04%4.73億 |
| 主營業務成本 | -11.43%10.8億 | 19.58%12.19億 | -3.87%2.83億 | 71.19%3.71億 | 12.85%2.73億 | 9.61%2.92億 | 0.28%10.2億 | 11.06%2.94億 | 12.62%2.17億 | -8.04%2.42億 |
| 毛利 | 6.63%11.74億 | 13.22%11.01億 | 6.22%2.66億 | 31.98%2.95億 | 15.96%2.68億 | 1.68%2.71億 | -11.41%9.72億 | 1.25%2.5億 | -16.09%2.24億 | -23.03%2.31億 |
| 營業費用 | 8.56%13.82億 | 6.75%12.73億 | -1.49%3.11億 | 6.45%3.06億 | 14.18%3.31億 | 8.53%3.24億 | -32.96%11.93億 | -25.16%3.16億 | -36.23%2.88億 | -36.99%2.9億 |
| 營業利潤 | -20.91%-2.08億 | 21.79%-1.72億 | 30.98%-4,522.6萬 | 82.52%-1,121.8萬 | -7.19%-6,302.5萬 | -65.89%-5,286.7萬 | 67.67%-2.2億 | 62.53%-6,552.4萬 | 65.28%-6,416.6萬 | 63.23%-5,879.6萬 |
| 營業外利息收入與支出淨額 | -3,574.85%-3,156.7萬 | 92.26%-85.9萬 | -1,515.38%-63萬 | -4萬 | 54.62%-5.4萬 | 98.77%-13.5萬 | 84.53%-1,109.9萬 | 99.82%-3.9萬 | 0 | 95.93%-11.9萬 |
| 營業外利息收入 | 4,550.00%9.3萬 | 0.00%2,000 | 0.00%1,000 | --0 | 0.00%1,000 | --0 | 0.00%2,000 | 0.00%1,000 | --0 | 110.00%1,000 |
| 營業外利息支出 | --293.4萬 | --0 | --0 | --0 | --0 | --0 | -73.22%102.7萬 | --0 | --0 | --0 |
| 其他財務費用 | 3,236.35%2,872.6萬 | -91.45%86.1萬 | 1,477.50%63.1萬 | --4萬 | -54.17%5.5萬 | -98.64%13.5萬 | -85.17%1,007.4萬 | -99.77%4萬 | --0 | -95.88%12萬 |
| 投資淨收益 | -100.27%-1.1萬 | 3,038.28%401.7萬 | 0 | 0 | -8,000 | 402.5萬 | 164.97%12.8萬 | 120.81%3.6萬 | 196.30%10.4萬 | |
| 被指定為現金流套期的金融工具損益 | ||||||||||
| 終止確認可供出售金融資產損益 | ||||||||||
| 聯營企業及其他參股權益產生的收益 | ||||||||||
| 特殊收入(費用) | -1,257.34%-4,006.7萬 | 112.29%346.2萬 | 66.01%-22.4萬 | 83.16%-463.1萬 | -162.9萬 | 994.6萬 | -401.80%-2,816.4萬 | -107.06%-65.9萬 | -2,750.5萬 | 0 |
| 減:其他特殊費用 | 361.82%2,904.4萬 | ---1,109.3萬 | --0 | --0 | --0 | ---1,109.3萬 | ---- | ---- | ---- | ---- |
| 減:勾銷 | 44.45%1,102.3萬 | -72.91%763.1萬 | -66.01%22.4萬 | -83.16%463.1萬 | --162.9萬 | --114.7萬 | 401.80%2,816.4萬 | 107.06%65.9萬 | --2,750.5萬 | --0 |
| 其他營業外收入(費用) | 128.44%1,102.7萬 | -29.42%482.7萬 | -76.47%141.7萬 | 223.16%114.4萬 | 124.32%116.2萬 | 2,144.44%110.4萬 | 451.53%683.9萬 | 727.06%602.1萬 | 348.10%35.4萬 | 32.82%51.8萬 |
| 稅前利潤 | -67.19%-2.69億 | 36.32%-1.61億 | 25.77%-4,466.3萬 | 83.84%-1,474.4萬 | -8.81%-6,355.5萬 | 11.53%-3,792.4萬 | 66.00%-2.53億 | 67.69%-6,016.5萬 | 51.89%-9,121.2萬 | 64.05%-5,840.9萬 |
| 所得稅 | -48.08%778.4萬 | 334.05%1,499.2萬 | 109.64%452.4萬 | 1,961.64%779.3萬 | 178.40%135.3萬 | 206.02%132.2萬 | 15.09%345.4萬 | 376.38%215.8萬 | 215.00%37.8萬 | -72.39%48.6萬 |
| 除稅後利潤 | -57.36%-2.77億 | 31.33%-1.76億 | 21.08%-4,918.7萬 | 75.39%-2,253.7萬 | -10.21%-6,490.8萬 | 9.35%-3,924.7萬 | 65.67%-2.56億 | 66.61%-6,232.3萬 | 51.72%-9,158.9萬 | 64.13%-5,889.6萬 |
| 持續經營利潤 | -57.36%-2.77億 | 31.33%-1.76億 | 21.08%-4,918.7萬 | 75.39%-2,253.7萬 | -10.21%-6,490.8萬 | 9.36%-3,924.6萬 | 65.67%-2.56億 | 66.61%-6,232.3萬 | 51.72%-9,159萬 | 64.13%-5,889.5萬 |
| 歸屬于少數股東的淨利潤 | 0 | 0 | 0 | 0 | 0 | |||||
| 歸屬於母公司的淨利潤 | -57.36%-2.77億 | 31.33%-1.76億 | 21.08%-4,918.7萬 | 75.39%-2,253.7萬 | -10.21%-6,490.8萬 | 9.35%-3,924.7萬 | 65.67%-2.56億 | 66.61%-6,232.3萬 | 51.72%-9,158.9萬 | 64.13%-5,889.6萬 |
| 優先股派息 | ||||||||||
| 其他優先股派息 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| 歸屬于普通股股東的淨利潤 | -57.36%-2.77億 | 31.33%-1.76億 | 21.08%-4,918.7萬 | 75.39%-2,253.7萬 | -10.21%-6,490.8萬 | 9.35%-3,924.7萬 | 65.67%-2.56億 | 66.61%-6,232.3萬 | 51.72%-9,158.9萬 | 64.13%-5,889.6萬 |
| 總派息金額 | ||||||||||
| 基本每股收益 | -31.72%-4.36 | 39.38%-3.31 | 26.23%-0.9 | 79.08%-0.41 | 3.13%-1.24 | 24.00%-0.76 | 73.94%-5.46 | 75.79%-1.22 | 61.87%-1.96 | 72.23%-1.28 |
| 稀釋每股收益 | -31.72%-4.36 | 39.38%-3.31 | 26.23%-0.9 | 78.94%-0.4127 | 3.13%-1.24 | 24.00%-0.76 | 73.94%-5.46 | 75.86%-1.22 | 61.87%-1.96 | 72.23%-1.28 |
| 每股派息 | ||||||||||
| 貨幣單位 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 | 日元 |
| 會計準則 | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |